Statements (131)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Grifols
|
| gptkbp:acquisition |
Ava Gen, Inc.
|
| gptkbp:audience |
High satisfaction rates.
|
| gptkbp:awards |
Best Places to Work (2020)
|
| gptkbp:benefits |
Comprehensive packages.
|
| gptkbp:brand |
Growing brand awareness.
|
| gptkbp:business_model |
B2 B and B2 C.
Patient-centered approach. |
| gptkbp:ceo |
Harry Stylli
Jessica M. M. M. Stylli |
| gptkbp:clinical_trial |
Ongoing
Ongoing studies. Published findings. CLIA certified. Focus on genetic testing. Oncology and reproductive health. |
| gptkbp:collaborations |
Academic institutions.
Academic partnerships. |
| gptkbp:community_engagement |
Health education initiatives.
Health awareness campaigns. |
| gptkbp:community_involvement |
Local outreach.
Health fairs and workshops. |
| gptkbp:community_programs |
Health initiatives.
|
| gptkbp:community_support |
Local initiatives.
|
| gptkbp:customer_base |
Hospitals and clinics.
|
| gptkbp:customer_support |
Dedicated support team.
|
| gptkbp:data_privacy |
Compliance with regulations.
|
| gptkbp:developer |
Training programs.
|
| gptkbp:economic_activity |
Strategic initiatives.
|
| gptkbp:economic_impact |
New regions.
|
| gptkbp:education |
Informative resources.
|
| gptkbp:employees |
200+
|
| gptkbp:feedback |
Regular surveys.
High ratings. |
| gptkbp:financial_performance |
Positive growth trajectory.
Strong balance sheet. Strong revenue growth. |
| gptkbp:financial_products |
Stable growth.
Publicly traded financial reports. |
| gptkbp:focus |
Women’s health
|
| gptkbp:founded |
gptkb:2010
gptkb:San_Diego,_California |
| gptkbp:founder |
Harry Stylli
|
| gptkbp:future_plans |
Expand internationally.
|
| gptkbp:governed_by |
Best practices.
Strategic growth. |
| gptkbp:headcount |
Approx. 250
|
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| gptkbp:healthcare |
Innovative testing.
Leading-edge research. New testing technologies. Pioneering new tests. Promoting wellness. |
| gptkbp:hosts_events |
Industry conferences.
|
| https://www.w3.org/2000/01/rdf-schema#label |
Progenity, Inc.
|
| gptkbp:industry |
gptkb:Company
|
| gptkbp:innovation |
Innovative solutions.
Continuous product development. New service lines. Cutting-edge solutions. Innovative testing methods. |
| gptkbp:invention |
Multiple patents in genetic testing
|
| gptkbp:investment |
Venture capital firms
Unique offerings. Transparent communication. Positive projections. $100 million raised in funding. |
| gptkbp:key_people |
gptkb:Mark_Mc_Gowan
|
| gptkbp:language |
Inclusive and diverse.
Inclusive environment. |
| gptkbp:leadership |
Diverse executive team.
Industry recognition. Industry leader. Leading position in sector. |
| gptkbp:market |
North America.
Consumer trends. Consumer insights. Competitive advantage. New tests annually. |
| gptkbp:market_cap |
$50 million (2021)
|
| gptkbp:marketing_strategy |
Targeted marketing campaigns.
Long-term vision. |
| gptkbp:mission |
Improve health outcomes through genetic testing.
|
| gptkbp:partnership |
gptkb:University_of_California,_San_Diego
Strategic alliances. Biotech companies. Collaborative innovations. |
| gptkbp:partnerships |
Collaborative projects.
Various healthcare providers. Collaborate with startups. Partnerships with providers. |
| gptkbp:population_trend |
Staying ahead of competition.
|
| gptkbp:products |
Genetic testing
User-centered design. High standards. |
| gptkbp:provides_information_on |
Evidence-based practices.
Best practices. |
| gptkbp:publishes |
Research articles.
|
| gptkbp:receives_funding_from |
Grants and investments.
|
| gptkbp:regulatory_compliance |
Adheres to industry standards.
FDA approved tests. |
| gptkbp:research_and_development |
gptkb:Database_Management_System
|
| gptkbp:research_focus |
Prenatal testing
Genetic disorders. |
| gptkbp:revenue |
$20 million (2020)
|
| gptkbp:scholarships |
Grants and funding.
|
| gptkbp:services |
Laboratory services
|
| gptkbp:side_effect |
Improving patient outcomes.
Significant contributions. |
| gptkbp:social_responsibility |
Sustainability initiatives.
Ethical practices. Ethical standards. |
| gptkbp:sponsor |
Active communication.
|
| gptkbp:strategic_importance |
Expand product offerings.
|
| gptkbp:student_enrollment |
Strong culture.
|
| gptkbp:subsidiary |
Progenity Diagnostics
|
| gptkbp:sustainability_initiatives |
Reduce carbon footprint.
Focus on genetic health. |
| gptkbp:symbol |
PROG
|
| gptkbp:technology |
Next-generation sequencing
Advanced systems. Seamless systems. |
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:training |
Ongoing professional development.
|
| gptkbp:treatment |
Data-driven results.
Improved health results. |
| gptkbp:type |
gptkb:Company
|
| gptkbp:type_of_care |
Focus on quality.
|
| gptkbp:website |
www.progenity.com
|